Skip to main content
. 2013 Nov 6;13(2):566–579. doi: 10.1074/mcp.M113.028969

Table II. N-glycans identified in the recombinant xyloglucan-specific endoglucanase inhibitor protein (XEGIP).

Peptide sequence Glycan composition Mass of glycan RT (min) m/z z M+H Peptide+H
ELANVTR (Hex)4(HexNAc)2 1054.36 10.97 928.90 2 1856.80 802.44
ELANVTR (Hex)5(HexNAc)2 1216.36 10.97 1009.90 2 2018.80 802.44
ELANVTR (Hex)6(HexNAc)2 1378.36 10.97 1090.90 2 2180.80 802.44
ELANVTR (Hex)7(HexNAc)2* 1540.36 10.97 1171.90 2 2342.80 802.44
ELANVTR (Hex)8(HexNAc)2* 1702.36 10.97 835.60 3 2504.80 802.44
ELANVTR (Hex)9(HexNAc)2* 1863.76 10.97 889.4 3 2666.20 802.44
QNQTSFRPK (Hex)6(HexNAc)2 1378.12 11.36 822.80 3 2466.40 1088.28
QNQTSFRPK (Hex)7(HexNAc)2 1540.12 11.36 876.80 3 2628.40 1088.28
QNQTSFRPK (Hex)8(HexNAc)2* 1702.12 11.36 930.80 3 2790.40 1088.28
QNQTSFRPK (Hex)9(HexNAc)2* 1540.12 11.36 984.80 3 2952.40 1088.28
VVPINTTLLSIDNQGVGGTK (Hex)4(HexNAc)2 1054.08 21.49 1027.40 3 3080.20 2026.12
VVPINTTLLSIDNQGVGGTK (Hex)5(HexNAc)2 1216.08 21.49 1081.40 3 3242.20 2026.12
VVPINTTLLSIDNQGVGGTK (Hex)6(HexNAc)2 1378.38 21.49 1135.50 3 3404.50 2026.12
VVPINTTLLSIDNQGVGGTK (Hex)7(HexNAc)2* 1540.68 21.49 1189.60 3 3566.80 2026.12
VVPINTTLLSIDNQGVGGTK (Hex)8(HexNAc)2* 1702.68 21.49 1243.60 3 3728.80 2026.12
VVPINTTLLSIDNQGVGGTK (Hex)9(HexNAc)2 1864.08 21.49 1297.40 3 3890.20 2026.12
QTTCANFNFTSIDdpaflyk (Hex)5(HexNAc)2 1216.42 25.57 1190.50 3 3569.50 2353.08
QTTCANFNFTSIDdpaflyk (Hex)6(HexNAc)2 1378.12 25.57 1244.40 3 3731.20 2353.08
QTTCANFNFTSIDdpaflyk (Hex)7(HexNAc)2 1540.72 25.57 1298.60 3 3893.80 2353.08
QTTCANFNFTSIDdpaflyk (Hex)8(HexNAc)2a 1702.12 25.57 1352.40 3 4055.20 2353.08
QTTCANFNFTSIDdpaflyk (Hex)9(HexNAc)2a 1864.42 25.57 1406.50 3 4217.50 2353.08

a High abundant glycoforms. The N-glycans and glycoforms were identified by nanoLC-PI scan (+204) triggered IDA analysis. Lower case letters in the peptide sequences refer to amino acid residues in the TAP tag fusion.